Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Articles, Cellular/Molecular

Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases

Saskia M. Burm, Ella A. Zuiderwijk-Sick, Anke E.J. ‘t Jong, Céline van der Putten, Jennifer Veth, Ivanela Kondova and Jeffrey J. Bajramovic
Journal of Neuroscience 14 January 2015, 35 (2) 678-687; https://doi.org/10.1523/JNEUROSCI.2510-14.2015
Saskia M. Burm
1Alternatives Unit,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ella A. Zuiderwijk-Sick
1Alternatives Unit,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anke E.J. ‘t Jong
1Alternatives Unit,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Céline van der Putten
1Alternatives Unit,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Veth
1Alternatives Unit,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivanela Kondova
2Animal Science Department, Biomedical Primate Research Centre, 2288 GJ Rijswijk, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey J. Bajramovic
1Alternatives Unit,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeffrey J. Bajramovic
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Inflammasomes are multiprotein complexes that link pathogen recognition and cellular stress to the processing of the proinflammatory cytokine interleukin-1β (IL-1β). Whereas inflammasome-mediated activation is heavily studied in hematopoietic macrophages and dendritic cells, much less is known about microglia, resident tissue macrophages of the brain that originate from a distinct progenitor. To directly compare inflammasome-mediated activation in different types of macrophages, we isolated primary microglia and hematopoietic macrophages from adult, healthy rhesus macaques. We analyzed the expression profile of NOD (nucleotide-binding oligomerization domain)-like receptors, adaptor proteins, and caspases and characterized inflammasome activation and regulation in detail. We here demonstrate that primary microglia can respond to the same innate stimuli as hematopoietic macrophages. However, microglial responses are more persistent due to lack of negative regulation on pro-IL-1β expression. In addition, we show that while caspase 1, 4, and 5 activation is pivotal for inflammasome-induced IL-1β secretion by hematopoietic macrophages, microglial secretion of IL-1β is only partially dependent on these inflammatory caspases. These results identify key cell type-specific differences that may aid the development of strategies to modulate innate immune responses in the brain.

  • IL-1β
  • inflammasome
  • inflammatory caspases
  • macrophages
  • microglia

Introduction

Microglia are the resident tissue macrophages of the CNS. Like other macrophages, they express multiple receptors of the innate immune system, including Toll-like receptors (TLRs), NOD (nucleotide-binding oligomerization domain)-like receptors (NLRs), C-type lectin receptors, and retinoic acid-inducible gene-I-like receptors (Olson and Miller, 2004; Zuiderwijk-Sick et al., 2007; Furr et al., 2008; Shah et al., 2008; Shi et al., 2012). Recent studies have implicated NLR-mediated activation of microglia in several neurodegenerative (Salminen et al., 2008; Heneka et al., 2013) and infectious brain diseases (Hafner-Bratkovič et al., 2012; Jamilloux et al., 2013), providing an impetus for more detailed studies of this receptor family.

NLRs can sense disturbances in cellular homeostasis caused by amongst others pathogens, large protein aggregates, and neighboring cell death. To date, 23 NLRs have been described for humans (Martinon et al., 2009). Ligand recognition by NOD1 and NOD2 can directly induce transcription of proinflammatory cytokines and chemokines via NFκB and IRF3 signaling (Ting et al., 2010). Other NLRs, such as NALP1 (NACHT-, LRR-, and PYD-containing protein 1), NALP3, NALP7, AIM2 (absent in melanoma 2), and IPAF (ICE-protease activating factor) can form multiprotein complexes called inflammasomes. These receptors can either directly or indirectly via the adaptor proteins ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or CARDINAL (CARD inhibitor of NF-κB-activating ligands) interact with inflammatory caspases and activate them. In turn, activated caspases can process precursor proteins, such as pro-IL-1β, to their bioactive and secreted forms. Thereby NLRs link perturbances in cellular homeostasis to the production of proinflammatory cytokines (Martinon et al., 2009; Latz, 2010; Khare et al., 2012).

Inflammasome-mediated activation of microglia is involved in both infectious (Chang et al., 2012; Kaushik et al., 2012; Lee et al., 2013) and noninfectious (Halle et al., 2008; Abulafia et al., 2009; Meissner et al., 2010) neurological diseases. Microglia express various components of the inflammasome, including NALP1, NALP3, ASC, and caspase 1 (Abulafia et al., 2009; Jamilloux et al., 2013; Shi et al., 2013). In addition, microglia can be induced to express pro-IL-1β, which can be processed to bioactive and secreted IL-1β in response to pathogens, protein aggregates, and more general cellular stressors, such as ATP and reactive oxygen species (Halle et al., 2008; Abulafia et al., 2009; Terada et al., 2010; Hanamsagar et al., 2011; Wu et al., 2013; Walsh et al., 2014).

Although microglia resemble hematopoietic macrophages both in phenotype and function, it has recently been uncovered that they originate from a different progenitor (Ginhoux et al., 2010). Furthermore, there are indications that regulation of signaling by innate immune receptors is different in microglia (Xiao et al., 2013), and microglia have been reported to specifically employ caspases 3/7 and 8 during inflammatory conditions (Burguillos et al., 2011). To directly compare inflammasome-mediated activation in different types of macrophages in an outbred system with close resemblance to humans, we isolated primary microglia and hematopoietic macrophages from adult, healthy rhesus macaques. We analyzed the expression profile of NLRs, adaptor proteins, and caspases and characterized inflammasome activation and regulation in detail. Our data reveal important cell type-specific differences pertaining to the negative regulation of pro-IL-1β expression as well as to the inflammasome-induced enzymatic processing of pro-IL-1β.

Materials and Methods

Animals and cell culture.

Brain, bone marrow, and blood were obtained from adult rhesus monkeys (Macaca mulatta) of either sex without neurological disease that became available from the outbred breeding colony. No animals were sacrificed for the exclusive purpose of the initiation of primary cell cultures. Better use of experimental animals contributes to the priority 3Rs program of the Biomedical Primate Research Centre. Individual identification data of the animals are listed in Table 1. Primary microglia and bone marrow-derived macrophages were isolated and cultured as described previously (Zuiderwijk-Sick et al., 2007; van der Putten et al., 2009). In short, microglia isolations were initiated from cubes of ∼3 g of prefrontal subcortical white matter tissue that were manually depleted of blood vessels and meninges. These were chopped into cubes of <2 mm3 by using gentleMACS C tubes (Miltenyi Biotec) and incubated for 20 min at 37°C in PBS (Thermo Fisher Scientific) containing 0.25% (w/v) trypsin (Thermo Fisher Scientific) and 0.2 mg/ml bovine pancreatic DNase I (Roche Diagnostics). The pellet (no centrifugation) was washed, passed over a 100 μm nylon cell strainer (Corning), and spun for 7 min at 524 × g. After resuspending, this was followed by Percoll (GE Healthcare Bio-Sciences) gradient centrifugation for 30 min (1561 × g; slow brake). The pellet was washed and residual erythrocytes were depleted by hypotonic shock for 7 min on ice in milli-Q supplemented with 155 mm NH4Cl (Calbiochem), 1 mm KHCO3 (Merck), and 0.2% (w/v) bovine serum albumin (Sigma-Aldrich). After a final wash, cells were plated in tissue culture treated 6-well or 24-well plates (Corning Costar) in 1:1 v/v DMEM (high glucose)/HAM F10 Nutrient Mixture supplemented with 10% v/v heat-inactivated FCS, 0.5 mm glutamax, 50 U/ml penicillin, and 50 μg/ml streptomycin (all Thermo Fisher Scientific). After overnight incubation, unattached cells and myelin debris were removed by washing with PBS and attached cells were cultured in fresh medium supplemented with 20 ng/ml macrophage colony-stimulating factor (M-CSF; PeproTech).

View this table:
  • View inline
  • View popup
Table 1.

Individual identification data of rhesus macaques

Primary bone marrow-derived macrophages were isolated by flushing the bone marrow from the femur (∼4 cm) with PBS, followed by passing the suspension over a 100 μm nylon cell strainer (Corning) and gradient centrifugation using Lymphoprep (Axis-Shield PoC) according to manufacturer's protocol. Cells were plated in tissue culture-treated 6-well or 24-well plates (Corning Costar) in RPMI (Roswell Park Memorial Institute) 1640 medium supplemented with 10% v/v heat-inactivated FCS, 2 mm glutamax, 50 U/ml penicillin, 50 μg/ml streptomycin (all Thermo Fisher Scientific), and 20 ng/ml M-CSF (PeproTech).

Primary blood CD14+ (cluster of differentiation antigen 14-positive) macrophages were isolated from heparinized blood using Lymphoprep (Axis-Shield PoC) and leucosep separation tubes. Interphases were collected and CD14+ monocytes were isolated using CD14+ microbeads (Miltenyi Biotec) and a magnetic activated cell sorting separation system. CD14+ cells were plated in tissue culture-treated 6-well or 24-well plates (Corning Costar) in RPMI 1640 medium supplemented with 10% v/v heat-inactivated FCS, 2 mm glutamax, 50 U/ml penicillin, 50 μg/ml streptomycin (all Thermo Fisher Scientific), and 20 ng/ml M-CSF (PeproTech).

After isolation, cell populations were kept in culture for 7 or 8 d (without passaging) and received 1:1 fresh medium every 3–4 d supplemented with 20 ng/ml M-CSF (PeproTech). Cell cultures were synchronized for medium changes as well as for exposure to experimental stimuli. Different cell populations were analyzed (data not shown) for purity (there were no significant differences in percentage CD11b+ cells), morphological criteria indicative of activation (absent), and proliferation rate by Ki-67 immunostainings (there were no significant differences in percentage proliferating cells at time of stimulation). All cell culture media were analyzed for possible LPS contamination using a TLR4 bioassay: none of the media contained >10 fg of LPS/ml (data not shown).

Antibodies and reagents.

Monoclonal antibodies against human caspase 1 (IMG5028, Novus Biologicals) and polyclonal antibodies against human caspase 4 and 5 (4450S and 4429S, Cell Signaling Technology) and human IL-1β (H-153, Santa Cruz Biotechnology) were used. Secondary mouse anti-rabbit-IgG-HRP and goat anti-mouse-IgG-HRP were obtained from Jackson ImmunoResearch Laboratories.

TLR ligands used were TLR1/2 agonist Pam3CSK4 (500 ng/ml), TLR3 agonist polyiosinic-polycytidylic acid (20 μg/ml), TLR8 agonist CL075 (1 μg/ml; all Invivogen) and TLR4 agonist LPS (100 ng/ml, unless indicated otherwise; from Escherichia coli serotype O26:B6; Sigma-Aldrich). Inflammasome-activating agents used were monosodium urate (MSU) crystals (150 μg/ml; Invivogen), ATP (5 mm), and silica (500 μg/ml; Sigma-Aldrich).

Fluorochrome inhibitor of caspase assays (FLICA; AbD Serotec) to determine specific caspase 1 activity were performed according to manufacturer's instructions. Caspase inhibitors specific for caspase 1 (Z-YVAD-FMK; 10–40 μm), caspase 4 (Z-LEVD-FMK; 10–40 μm), and caspase 5 (Z-WEHD-FMK; 10–40 μm) were from BioVision. Concentrations of inflammasome-activating agents and caspase inhibitors were based on earlier studies (Zuiderwijk-Sick et al., 2007; Halle et al., 2008; Zhou et al., 2011).

RNA isolation, cDNA synthesis, and real-time PCRs.

Total cellular RNA was isolated using TriReagent (Sigma-Aldrich) or the RNeasy minikit (Qiagen) according to manufacturer's protocol. Subsequently, 1 μg of template mRNA was reverse transcribed into cDNA with the RevertAid First Strand cDNA synthesis kit (Thermo Fisher Scientific) according to manufacturer's protocol. Probes for real-time PCRs were designed using the Universal Probe Library design center (Roche Applied Science). Real-time quantitative PCRs were performed on the CFX96 real-time PCR detection system (Bio-rad Laboratories) using primer (Thermo Fisher Scientific) and probe (Exiqon ProbeLibrary, Roche) combinations listed in Table 2, and iTaq Universal Probes Supermix (Biorad). Relative gene expression was standardized to β-actin using the Pfaffl method (Pfaffl, 2001).

View this table:
  • View inline
  • View popup
Table 2.

Overview of primer/probe combinations used for real-time quantitative PCR

Cytokine analysis.

Sandwich ELISA kits for human IL-1β (R&D Systems) were used for quantification of IL-1β in cell culture supernatants according to manufacturer's instructions.

Western blot analysis.

Culture supernatants were collected and residual crystals or cellular debris was removed by short centrifugation at 12,000 × g. To remove large proteins, 1:1 v/v acentonitrile (ICN Biomedicals) was added, followed by 30 min incubation at room temperature and short centrifugation at 12,000 × g. Thereafter, supernatants were concentrated using 10 kDa microcentrifuge tubes (Merck). Concentrates were collected and standardized to volume.

Cell lysates were prepared in mammalian protein extraction reagent supplemented with Halt protease and phosphatase inhibitor mixture (Thermo Fisher Scientific) according to manufacturer's instructions. Cell lysates were standardized to protein concentrations that were determined using Bradford assays (Thermo Fisher Scientific).

Culture supernatants and cell lysates were separated on 12% Bis/Tris gel in NuPage MOPS [3-(N-morpholino)propanesulfonic acid] buffer (Thermo Fisher Scientific). Proteins were transferred to nitrocellulose membranes (GE Healthcare Bio-Sciences) by semidry blotting. Membranes were probed with indicated primary and secondary antibodies, and developed with chemiluminescence (Thermo Fisher Scientific).

Statistics.

All data are depicted as means ± SD. Graphpad Prism 6 (Graphpad Software, 2014, version 6.0e) for Macintosh was used for graphical representations. Statistical analyses were performed using Microsoft Excel for Mac (Microsoft, 2011, version 14.4.1) and the R statistical package (R Development Core Team, 2009, version 3.02).

Results

We first assessed mRNA expression levels of different inflammasome components in primary microglia, bone marrow-derived macrophages (BMDMs), and blood CD14+-derived macrophages (CD14Ms; Fig. 1A). mRNA transcripts for NLR family members NALP1–NALP3, AIM2, IPAF, NAIP (neuronal aptosis inhibitory protein), MALT (mucosa-associated lymphoid tissue lymphoma-translocation gene), and NOD1–NOD4 were detectable in all cell types, while transcripts for NALP4–NALP14 were below detection levels. In addition, all cell types expressed transcripts for the adaptor proteins ASC, CARDINAL, EBP1 (end binding protein 1), and PKR (double-stranded RNA-activated protein kinase) as well as transcripts for caspase 1, 3–5, 7, and 8. Expression levels of adaptor protein- and caspase-encoding transcripts were relatively abundant when compared with levels of NLR-encoding transcripts.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

mRNA expression profile of inflammasome components in primary rhesus microglia, BMDMs, and CD14Ms. A, mRNA expression levels of NLRs, adaptor proteins, and caspases in primary rhesus microglia, BMDMs, and CD14Ms. mRNA expression levels of genes of interest (GOI) are expressed relative to reference gene [β-actin (β-ACT)] mRNA expression levels. Data are represented as means ± SD. NALP4-NALP11, NALP13, and NALP14 mRNA expression levels were below detection limits and low expression levels of NALP12 prohibited reliable quantification of all samples. B, Relative mRNA expression levels compared between microglia and BMDMs, between microglia and CD14Ms, and between CD14Ms and BMDMs. C, Fold increases in relative mRNA expression levels of NLRs, adaptor proteins, and caspases after 16 h exposure to LPS (100 ng/ml) in microglia, BMDMs, and CD14Ms. Data are represented as mean values. D, Relative mRNA expression levels after 16 h exposure to LPS (100 ng/ml) compared between microglia and BMDMs, between microglia and CD14Ms, and between CD14Ms and BMDMs. *p < 0.05, **p < 0.01; ANOVA with Tukey's HSD correction.

The expression profiles are consistent with the notion that all these cell types can form functional inflammasomes. Yet, comparison of relative mRNA expression levels of microglia, BMDMs, and CD14Ms (Fig. 1B) revealed interesting differences. Where mRNA expression levels in BMDMs and CD14Ms were comparable, microglia expressed significantly lower levels of AIM2, NOD1, NOD3, caspase 1, 3, 4, and 5-encoding mRNA transcripts compared to BMDMs. In addition, levels of caspase 4 and 5-encoding mRNA transcripts were lower in microglia when compared with CD14Ms, although this was not significant.

As in vitro inflammasome activation is most often monitored in cells that have been primed with a TLR agonist (Martinon et al., 2002; Netea et al., 2009; Zhou et al., 2011), we also analyzed mRNA expression levels after overnight exposure to the TLR4 agonist LPS. Comparison to nonstimulated cells revealed LPS-induced changes in mRNA expression levels of many inflammasome components in all cell types (Fig. 1C). Priming of microglia significantly enhanced expression levels of PKR and caspase 1, 4, and 5 transcripts. Comparison of relative expression levels between cell types after LPS priming revealed that the mRNA expression profile of microglia now more closely resembled that of hematopoietic macrophages (Fig. 1D). The expression levels of transcripts encoding caspase 1, 3, 4, and 5 were now similar in all macrophages, but LPS-primed microglia still expressed markedly lower levels of NOD3-encoding transcripts compared with BMDMs and CD14Ms.

For functional analysis of inflammasome-mediated activation in microglia and BMDMs, cells were primed with different TLR agonists before triggering the inflammasome with silica, MSU crystals, or ATP (Martinon et al., 2006; Zhou et al., 2011). Priming of microglia and BMDMs by exposure to TLR1/2, TLR4, or TLR8 agonists strongly induced pro-IL-1β-encoding mRNA expression levels, whereas exposure to a TLR3 agonist was much less effective (Fig. 2A). Consistent with literature (Halle et al., 2008; Netea et al., 2009), secretion of IL-1β protein in response to TLR priming alone was <500 pg/ml or below detection levels both in microglia as well as in BMDMs (Fig. 2B). Exposure of microglia and BMDMs that were primed with the TLR4 agonist LPS to inflammasome activators strongly induced processing and secretion of IL-1β (Fig. 2C,D). Whereas the physiological relevance of MSU and ATP for microglia is clear (Shi et al., 2003; Rock and Kono, 2008; Euser et al., 2009; Hanamsagar et al., 2011; Maetzler et al., 2011; McFarland et al., 2013; Martins et al., 2014), it is less likely that they will encounter silica. However, as silica and MSU were more potent in triggering inflammasome-mediated activation in microglia than ATP, we chose to continue our studies with these stimuli.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

TLR-mediated priming of microglia and BMDMs induces the expression of pro-IL-1β-encoding mRNA, but processing and secretion of IL-1β is measured only after inflammasome activation. A, Relative pro-IL-1β-encoding mRNA expression levels in primary rhesus microglia and BMDMs. Cells were exposed for 16 h to TLR1/2 (PAM3CSK4, 500 ng/ml), TLR3 (polyiosinic-polycytidylic acid, 20 μg/ml), TLR4 (LPS, 100 ng/ml), and TLR8 (CL075, 1 μg/ml) agonists. B, Levels of secreted IL-1β by TLR-primed microglia and BMDMs. C, Levels of secreted IL-1β by LPS-primed (100 ng/ml, 4 h) microglia and BMDMs exposed to inflammasome inducers silica (500 μg/ml, 6 h), MSU (150 μg/ml, 6 h), or ATP (5 mm, 6 h). *p < 0.05, **p < 0.01; paired t tests with Bonferroni's correction compared with unstimulated cells (-). D, Western blot analysis of pro-IL-1β and cleaved IL-1β protein in cell lysates (lys) and supernatant (sup) of LPS-primed (100 ng/ml, 4 h) microglia and BMDMs that were exposed to silica (500 μg/ml, 6 h), MSU (150 μg/ml, 6 h), or ATP (5 mm, 6 h). Arrows indicate molecular weight (MW) in kilodaltons.

We first characterized the influence of priming on inflammasome-mediated activation by varying the length of the priming period before inflammasome activation. In microglia, silica-induced IL-1β secretion was detectable from 2 h after LPS priming onwards and increased gradually for ≤12 h after LPS priming (Fig. 3A). Priming for >16 h led to lower levels of secreted IL-1β. In BMDMs, silica-induced IL-1β secretion was detected as early as 1 h after LPS priming. Much higher levels of secreted IL-1β were obtained if BMDMs were primed with LPS for 6–8 h, whereas priming for >8 h led to lower levels of secreted IL-1β (Fig. 3A). Similar differences in kinetics were found between microglia and CD14Ms and also applied to MSU-induced inflammasome activation. Analysis of the ratio of inflammasome-induced secretion of IL-1β after 16 h of LPS priming to inflammasome-induced secretion of IL-1β after 4 h of LPS priming confirmed that these kinetics differ significantly between microglia and hematopoietic macrophages (Fig. 3B).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Kinetics of IL-1β secretion by LPS-primed microglia differ from that by LPS-primed hematopoietic macrophages. A, Silica-induced (500 μg/ml, 6 h) IL-1β secretion in LPS-primed (100 ng/ml, indicated time points) microglia and BMDMs. Data of one representative donor of ≥3 independent experiments are shown and are represented as mean ± SD. B, Analysis of the ratio of inflammasome-induced IL-1β secretion after 16 h to inflammasome-induced IL-1β secretion after 4 h. Open symbols, Silica-induced IL-1β secretion; closed symbols, MSU-induced IL-1β secretion; *p < 0.05, **p < 0.01; paired t tests with Bonferroni's correction compared with microglia.

We examined whether the different kinetics of IL-1β secretion in microglia could be attributed to differences in sensitivity to LPS-induced signaling. However, basal expression levels of TLR2-, TLR4-, CD14-, and MyD88 (myeloid differentiation primary response 88)-encoding transcripts were similar for microglia and other macrophages (Fig. 4A). In addition, priming of microglia and BMDMs with different concentrations of LPS resulted in similar differences in IL-1β secretion profiles between microglia and BMDMs (Fig. 4B). Finally, we assessed pro-IL-1β-encoding mRNA levels in more detail after LPS priming (Fig. 4C). Pro-IL-1β mRNA transcripts were strongly induced already after 1 h of LPS priming in both microglia and BMDMs. However, while pro-IL-1β mRNA transcript levels were downregulated already 4 h after LPS priming in BMDMs, they remained high in microglia. Analysis of other cytokine-encoding mRNA transcripts after priming with LPS demonstrates that the lack of negative regulation on pro-IL-1β transcripts also applied to IL-1α and IL-8 (Fig. 4C). Other LPS-inducible transcripts like those of IL-1Rα (IL-1 receptor antagonist), IL-6, and TNF-α (tumor-necrosis factor α) were subject to regulation in both microglia as well as in BMDMs.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Negative regulation of pro-IL-1β transcription is impaired in microglia. A, Relative mRNA expression levels of TLR2, TLR4, CD14, and MyD88 in unprimed microglia, BMDMs, and CD14Ms. B, Silica-induced (500 μg/ml, 6 h) IL-1β secretion of microglia and BMDMs primed with different concentrations of LPS (4–500 ng/ml, 4 or 16 h). C, Relative pro-IL-1β, IL-1α, pro-IL-18, IL-1Rα, IL-8, IL-6, TNFα, and TGFβ (transforming growth factor β) mRNA expression levels in LPS-primed (100 ng/ml, indicated time points) microglia (n = 3) and BMDMs (n = 3). Data are represented as mean ± SD.

To examine the processing and secretion of IL-1β in more detail, we first monitored the activation of caspase 1, the principal inflammasome-activated caspase described (Martinon and Tschopp, 2004). To our surprise, silica-induced caspase 1 activation could not be detected in microglia that were primed with LPS for 4 h. Only after 16 h of LPS priming some caspase 1 activation could be observed (Fig. 5A). This was in marked contrast to BMDMs, where robust silica-induced caspase 1 activation was detectable 4 h after LPS priming, while longer priming resulted in decreased caspase 1 activation. Western blot analysis of caspase 1 expression revealed that although both microglia and BMDMs expressed caspase 1, BMDMs expressed an additional isoform at 30 kDa and an additional high molecular-weight band at 55 kDa, indicative of a protein complex (Fig. 5B). In addition, Western blot analysis revealed that both microglia and BMDM expressed approximately similar amounts of the inflammatory caspases 4 and 5 under basal conditions and after LPS priming. Similar to caspase 1, BMDMs expressed an additional isoform of caspase 4 at 40 kDa. To assess their functional involvement in the secretion of IL-1β, we specifically inhibited caspase 1, 4, and 5 before activating the inflammasome (Fig. 5C). In LPS-primed microglia and BMDMs, inhibition of caspase 1 inhibited silica-induced IL-1β secretion by ≤46 and 59% respectively. Inhibition of caspase 4 and 5 inhibited silica-induced IL-1β secretion in microglia by ≤41 and 53% respectively, compared with ≤84 and 86% inhibition in BMDMs respectively. Whereas inhibition of caspase 4 and 5 in BMDMs was clearly dose dependent, this was not the case for microglia, suggesting that exposure to even higher concentrations of caspase inhibitors would not lead to a further reduction in silica-induced IL-1β secretion in microglia. This could not be directly tested, as the necessary dissolvent controls affected cellular homeostasis (data not shown). However, simultaneous inhibition of caspase 1, 4, and 5 inhibited silica-induced IL-1β secretion in microglia by ≤38%, whereas this inhibited silica-induced IL-1β secretion in BMDMs by ≤84%. Together these data indicate that microglia are less dependent on inflammatory caspases than BMDMs for the secretion of silica-induced IL-1β.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Silica-induced IL-1β secretion in microglia is only partially dependent of caspase 1, 4, and 5. A, Silica-induced (500 μg/ml, 30 min) caspase 1 activation in LPS-primed (100 ng/ml, indicated time points) microglia and BMDMs. Caspase 1 activation was assessed using fluorochrome inhibitor of caspase (FLICA) assays and results in a green fluorescent signal. Nuclei are counterstained with DAPI. Original magnifications 400×. B, Western blot analysis of caspase 1, 4, and 5 expression in cell lysates of unprimed and LPS-primed (100 ng/ml, indicated time points) microglia and BMDMs. Arrows indicate molecular weight (MW) in kilodaltons. C, Analysis of silica-induced (500 μg/ml, 6 h) IL-1β secretion by LPS-primed (100 ng/ml, indicated time points) microglia and BMDMs in the presence of 10–40 μm specific caspase inhibitors or a combination of caspase 1, 4, and 5 inhibitors (10–20 μm each, all applied 15 min before silica activation). Data of one representative donor of ≥3 independent experiments are shown for the separate caspase inhibitors, while data of multiple donors are shown for the combination of the caspase inhibitors. IL-1β secretion is represented relative to DMSO controls (dotted line, 100%). DMSO or caspase inhibitors alone did not induce IL-1β secretion in unprimed or LPS-primed microglia and BMDMs. *p < 0.05, **p < 0.01, ***p < 0.001; paired t tests with Bonferroni's correction compared with DMSO controls.

Discussion

Although microglia have long been considered similar to other myeloid macrophages, it is becoming more and more apparent that they differ in many respects, as illustrated by the distinct roles that resident microglia and peripheral macrophages play in CNS injury (Raivich and Banati, 2004; Greenhalgh and David, 2014). Differences in regulation of innate immune responses (Xiao et al., 2013) and alternative use of caspases have been described for microglia in earlier studies (Burguillos et al., 2011). Our data now identify new and important cell type-specific differences in inflammasome-mediated responses.

Results from this study demonstrate that microglia and hematopoietic macrophages are in principle endowed with similar inflammasome machinery. Published or online datasets on gene expression profiles of rodent microglia and macrophages (Chiu et al., 2013; Hickman et al., 2013; Butovsky et al., 2014) did not reveal differences in expression levels of inflammasome components between microglia and hematopoietic macrophages and are thus in line with most of our results. However, we report here that there are relatively large differences for two transcripts in particular. Resting microglia express less caspase 4 and 5 than resting BMDMs and CD14Ms (Fig. 1A). As caspase 4 and 5 are not encoded for in rodents, which express the orthologue caspase 11 (Martinon and Tschopp, 2004), this is a new finding that underlines the added value of studies using primate material.

Furthermore, we show that although microglia and hematopoietic macrophages respond to the same innate stimuli, microglial IL-1β secretion is optimal when longer priming periods are used and is more persistent when compared with hematopoietic macrophages. Together, our data demonstrate that the latter is due to a lack of negative regulation at the transcriptional level. This not only applies to LPS-induced pro-IL-1β mRNA expression levels, but also to IL-1α and IL-8 mRNA expression levels. Transcription factor analysis (Champion ChiP Transcription Factor Search Portal, Qiagen; Lee et al., 1987; Cogswell et al., 1994; De Bosscher et al., 2003) revealed that the promoter regions of these cytokines share binding sites for the transcription factors NFκB, AP-1, C/EBPβ (CCAAT/enhancer binding protein β), and glucocorticoid receptor. Many proteins have been described that regulate the activation of these transcription factors, including regulatory proteins A20, SOCS1, TRIAD3A, SHP1, TOLLIP, IRAK-M (IL-1 receptor-associated kinase M), PELI1 (pellino E3 ubiquitin protein ligase 1), FLN29, and MAPK phosphatases (Bajramovic, 2011). In microglia specifically, PELI1 can positively regulate NFκB signaling (Xiao et al., 2013). However, mRNA expression levels of PELI1 in microglia and hematopoietic macrophages were similar (data not shown), rendering it unlikely that this can directly explain the observed lack of negative regulation in microglia. Interestingly, NOD3 (also called NLRC3) has been found to negatively regulate NFκB activation (Schneider et al., 2012). As our mRNA expression analysis revealed that microglia constitutively express much lower levels of NOD3-encoding transcripts than hematopoietic macrophages, NOD3 is an interesting candidate for future studies.

Various studies using primary microglia describe inflammasome-induced IL-1β secretion in response to protein aggregates and pathogens as caspase 1 dependent (Halle et al., 2008; Meissner et al., 2010; Terada et al., 2010; Hanamsagar et al., 2011; Hafner-Bratkovič et al., 2012; Jamilloux et al., 2013; Lee et al., 2013; Walsh et al., 2014). Our results confirm that microglial secretion of IL-1β is dependent on caspase 1, but also demonstrate that this dependence is only partial. In addition, we demonstrate that although caspase 4 and 5 are involved in both microglia and hematopoietic macrophages, their relative contribution to inflammasome-induced IL-1β secretion appears to be less important in microglia. Our data on the simultaneous inhibition of caspase 1, 4, and 5 are in line with this notion. It has been reported that activation of caspase 4 and 5 can potentiate the activity of caspase 1 (Martinon et al., 2002; Sollberger et al., 2012) and this process might well be less efficient in microglia.

Overall our data show that microglia are less dependent than BMDMs on inflammatory caspases for the processing and secretion of IL-1β and suggest that they also employ other mechanisms. Alternative mechanisms that have been described for IL-1β processing and secretion include activation of a noncanonical caspase 8 inflammasome (Gringhuis et al., 2012; Antonopoulos et al., 2013) and inflammasome-independent mechanisms, such as matrix metalloproteinases (Schönbeck et al., 1998), cathepsins (Edye et al., 2013), and serine proteases (Joosten et al., 2009; Stehlik, 2009; Karmakar et al., 2012; Cassel et al., 2014). Preliminary results from our laboratory indicate that inhibition of caspase 8 does not affect silica-induced IL-1β secretion in either microglia or BMDMs (data not shown). The relative contribution of other pathways in microglial IL-1β secretion remains to be investigated.

This study, describing cell type-specific differences in the negative regulation of pro-IL-1β expression and in the enzymatic processing of pro-IL-1β, concurs with recently described fundamental differences in inflammasome-mediated activation of monocytes and macrophages (Netea et al., 2009). Whether such differences are cell inherent (Ginhoux et al., 2010) or induced by prolonged exposure to the neuronal microenvironment is currently unknown. It also remains to be demonstrated how the differences described here translate to tissue-specific responses to chronic or acute cellular stress in vivo. Currently, inhibition of caspase 1 activation is considered a therapeutic strategy to reduce inflammation in neuroinflammatory diseases (Rabuffetti et al., 2000). Our results suggest that this strategy might only be partially effective on microglia. To develop therapeutic strategies that target IL-1β processing and secretion in microglia specifically, it is important to delineate the additional mechanisms used by microglia for the secretion of IL-1β.

Footnotes

  • This work was supported by the Dutch MS Research Foundation (MS12-805). We thank T. Haaksma for expert technical assistance. We thank Dr. E. Remarque for expert assistance with the statistical analyses and Drs. R. Bontrop, L.A. ‘t Hart, M.G. Netea, and J.M. van Noort for critically reading the manuscript.

  • The authors declare no competing financial interests.

  • Correspondence should be addressed to Jeffrey J. Bajramovic, PhD, Alternatives Unit, Biomedical Primate Research Centre, Lange Kleiweg 161, 2288 GJ Rijswijk, The Netherlands. bajramovic{at}bprc.nl

References

  1. ↵
    1. Abulafia DP,
    2. de Rivero Vaccari JP,
    3. Lozano JD,
    4. Lotocki G,
    5. Keane RW,
    6. Dietrich WD
    (2009) Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J Cereb Blood Flow Metab 29:534–544, doi:10.1038/jcbfm.2008.143, pmid:19066616.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Antonopoulos C,
    2. El Sanadi C,
    3. Kaiser WJ,
    4. Mocarski ES,
    5. Dubyak GR
    (2013) Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1beta via caspase-8 in dendritic cells. J Immunol 191:4789–4803, doi:10.4049/jimmunol.1300645, pmid:24078693.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Bajramovic JJ
    (2011) Regulation of innate immune responses in the central nervous system. CNS Neurol Disord Drug Targets 10:4–24, doi:10.2174/187152711794488610, pmid:21143142.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Burguillos MA,
    2. Deierborg T,
    3. Kavanagh E,
    4. Persson A,
    5. Hajji N,
    6. Garcia-Quintanilla A,
    7. Cano J,
    8. Brundin P,
    9. Englund E,
    10. Venero JL,
    11. Joseph B
    (2011) Caspase signalling controls microglia activation and neurotoxicity. Nature 472:319–324, doi:10.1038/nature09788, pmid:21389984.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Butovsky O,
    2. Jedrychowski MP,
    3. Moore CS,
    4. Cialic R,
    5. Lanser AJ,
    6. Gabriely G,
    7. Koeglsperger T,
    8. Dake B,
    9. Wu PM,
    10. Doykan CE,
    11. Fanek Z,
    12. Liu L,
    13. Chen Z,
    14. Rothstein JD,
    15. Ransohoff RM,
    16. Gygi SP,
    17. Antel JP,
    18. Weiner HL
    (2014) Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat Neurosci 17:131–143, doi:10.1038/nn.3599, pmid:24316888.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Cassel SL,
    2. Janczy JR,
    3. Bing X,
    4. Wilson SP,
    5. Olivier AK,
    6. Otero JE,
    7. Iwakura Y,
    8. Shayakhmetov DM,
    9. Bassuk AG,
    10. Abu-Amer Y,
    11. Brogden KA,
    12. Burns TL,
    13. Sutterwala FS,
    14. Ferguson PJ
    (2014) Inflammasome-independent IL-1beta mediates autoinflammatory disease in Pstpip2-deficient mice. Proc Natl Acad Sci U S A 111:1072–1077, doi:10.1073/pnas.1318685111, pmid:24395802.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Chang J,
    2. Yang L,
    3. Kouadir M,
    4. Peng Y,
    5. Zhang S,
    6. Shi F,
    7. Zhou X,
    8. Yin X,
    9. Zhao D
    (2012) Antibody-mediated inhibition of integrin alpha5beta1 blocks neurotoxic prion peptide PrP106–126-induced activation of BV2 microglia. J Mol Neurosci 48:248–252, doi:10.1007/s12031-012-9821-6, pmid:22648512.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Chiu IM,
    2. Morimoto ET,
    3. Goodarzi H,
    4. Liao JT,
    5. O'Keeffe S,
    6. Phatnani HP,
    7. Muratet M,
    8. Carroll MC,
    9. Levy S,
    10. Tavazoie S,
    11. Myers RM,
    12. Maniatis T
    (2013) A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep 4:385–401, doi:10.1016/j.celrep.2013.06.018, pmid:23850290.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Cogswell JP,
    2. Godlevski MM,
    3. Wisely GB,
    4. Clay WC,
    5. Leesnitzer LM,
    6. Ways JP,
    7. Gray JG
    (1994) NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J Immun 153:712–723, pmid:8021507.
    OpenUrlAbstract
  10. ↵
    1. De Bosscher K,
    2. Vanden Berghe W,
    3. Haegeman G
    (2003) The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24:488–522, doi:10.1210/er.2002-0006, pmid:12920152.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Edye ME,
    2. Lopez-Castejon G,
    3. Allan SM,
    4. Brough D
    (2013) Acidosis drives damage-associated molecular pattern (DAMP)-induced interleukin-1 secretion via a caspase-1-independent pathway. J Biol Chem 288:30485–30494, doi:10.1074/jbc.M113.478941, pmid:24022484.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Euser SM,
    2. Hofman A,
    3. Westendorp RG,
    4. Breteler MM
    (2009) Serum uric acid and cognitive function and dementia. Brain 132:377–382, doi:10.1093/brain/awn316, pmid:19036766.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Furr SR,
    2. Chauhan VS,
    3. Sterka D Jr.,
    4. Grdzelishvili V,
    5. Marriott I
    (2008) Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus. J Neurovirol 14:503–513, doi:10.1080/13550280802337217, pmid:18991139.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Ginhoux F,
    2. Greter M,
    3. Leboeuf M,
    4. Nandi S,
    5. See P,
    6. Gokhan S,
    7. Mehler MF,
    8. Conway SJ,
    9. Ng LG,
    10. Stanley ER,
    11. Samokhvalov IM,
    12. Merad M
    (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330:841–845, doi:10.1126/science.1194637, pmid:20966214.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Greenhalgh AD,
    2. David S
    (2014) Differences in the phagocytic response of microglia and peripheral macrophages after spinal cord injury and its effects on cell death. J Neurosci 34:6316–6322, doi:10.1523/JNEUROSCI.4912-13.2014, pmid:24790202.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Gringhuis SI,
    2. Kaptein TM,
    3. Wevers BA,
    4. Theelen B,
    5. van der Vlist M,
    6. Boekhout T,
    7. Geijtenbeek TB
    (2012) Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat Immunol 13:246–254, doi:10.1038/ni.2222, pmid:22267217.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Hafner-Bratkovič I,
    2. Benčina M,
    3. Fitzgerald KA,
    4. Golenbock D,
    5. Jerala R
    (2012) NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1beta and neuronal toxicity. Cell Mol Life Sci 69:4215–4228, doi:10.1007/s00018-012-1140-0, pmid:22926439.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Halle A,
    2. Hornung V,
    3. Petzold GC,
    4. Stewart CR,
    5. Monks BG,
    6. Reinheckel T,
    7. Fitzgerald KA,
    8. Latz E,
    9. Moore KJ,
    10. Golenbock DT
    (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857–865, doi:10.1038/ni.1636, pmid:18604209.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Hanamsagar R,
    2. Torres V,
    3. Kielian T
    (2011) Inflammasome activation and IL-1beta/IL-18 processing are influenced by distinct pathways in microglia. J Neurochem 119:736–748, doi:10.1111/j.1471-4159.2011.07481.x, pmid:21913925.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Heneka MT,
    2. Kummer MP,
    3. Stutz A,
    4. Delekate A,
    5. Schwartz S,
    6. Vieira-Saecker A,
    7. Griep A,
    8. Axt D,
    9. Remus A,
    10. Tzeng TC,
    11. Gelpi E,
    12. Halle A,
    13. Korte M,
    14. Latz E,
    15. Golenbock DT
    (2013) NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493:674–678, doi:10.1038/nature11729, pmid:23254930.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Hickman SE,
    2. Kingery ND,
    3. Ohsumi TK,
    4. Borowsky ML,
    5. Wang LC,
    6. Means TK,
    7. El Khoury J
    (2013) The microglial sensome revealed by direct RNA sequencing. Nat Neurosci 16:1896–1905, doi:10.1038/nn.3554, pmid:24162652.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Jamilloux Y,
    2. Pierini R,
    3. Querenet M,
    4. Juruj C,
    5. Fauchais AL,
    6. Jauberteau MO,
    7. Jarraud S,
    8. Lina G,
    9. Etienne J,
    10. Roy CR,
    11. Henry T,
    12. Davoust N,
    13. Ader F
    (2013) Inflammasome activation restricts Legionella pneumophila replication in primary microglial cells through flagellin detection. Glia 61:539–549, doi:10.1002/glia.22454, pmid:23355222.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Joosten LA,
    2. Netea MG,
    3. Fantuzzi G,
    4. Koenders MI,
    5. Helsen MM,
    6. Sparrer H,
    7. Pham CT,
    8. van der Meer JW,
    9. Dinarello CA,
    10. van den Berg WB
    (2009) Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum 60:3651–3662, doi:10.1002/art.25006, pmid:19950280.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Karmakar M,
    2. Sun Y,
    3. Hise AG,
    4. Rietsch A,
    5. Pearlman E
    (2012) Cutting edge: IL-1beta processing during Pseudomonas aeruginosa infection is mediated by neutrophil serine proteases and is independent of NLRC4 and caspase-1. J Immunol 189:4231–4235, doi:10.4049/jimmunol.1201447, pmid:23024281.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Kaushik DK,
    2. Gupta M,
    3. Kumawat KL,
    4. Basu A
    (2012) NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PloS One 7:e32270, doi:10.1371/journal.pone.0032270, pmid:22393394.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Khare S,
    2. Dorfleutner A,
    3. Bryan NB,
    4. Yun C,
    5. Radian AD,
    6. de Almeida L,
    7. Rojanasakul Y,
    8. Stehlik C
    (2012) An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophages. Immunity 36:464–476, doi:10.1016/j.immuni.2012.02.001, pmid:22361007.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Latz E
    (2010) The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 22:28–33, doi:10.1016/j.coi.2009.12.004, pmid:20060699.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Lee HM,
    2. Kang J,
    3. Lee SJ,
    4. Jo EK
    (2013) Microglial activation of the NLRP3 inflammasome by the priming signals derived from macrophages infected with mycobacteria. Glia 61:441–452, doi:10.1002/glia.22448, pmid:23280493.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Lee W,
    2. Mitchell P,
    3. Tjian R
    (1987) Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741–752, doi:10.1016/0092-8674(87)90612-X, pmid:3034433.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Maetzler W,
    2. Stapf AK,
    3. Schulte C,
    4. Hauser AK,
    5. Lerche S,
    6. Wurster I,
    7. Schleicher E,
    8. Melms A,
    9. Berg D
    (2011) Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-beta pathway. J Alzheimers Dis 27:119–126, doi:10.3233/JAD-2011-110587, pmid:21765209.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Martinon F,
    2. Tschopp J
    (2004) Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561–574, doi:10.1016/j.cell.2004.05.004, pmid:15163405.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Martinon F,
    2. Burns K,
    3. Tschopp J
    (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–426, doi:10.1016/S1097-2765(02)00599-3, pmid:12191486.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Martinon F,
    2. Pétrilli V,
    3. Mayor A,
    4. Tardivel A,
    5. Tschopp J
    (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241, doi:10.1038/nature04516, pmid:16407889.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Martinon F,
    2. Mayor A,
    3. Tschopp J
    (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229–265, doi:10.1146/annurev.immunol.021908.132715, pmid:19302040.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Martins I,
    2. Wang Y,
    3. Michaud M,
    4. Ma Y,
    5. Sukkurwala AQ,
    6. Shen S,
    7. Kepp O,
    8. Métivier D,
    9. Galluzzi L,
    10. Perfettini JL,
    11. Zitvogel L,
    12. Kroemer G
    (2014) Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ 21:79–91, doi:10.1038/cdd.2013.75, pmid:23852373.
    OpenUrlCrossRefPubMed
  36. ↵
    1. McFarland NR,
    2. Burdett T,
    3. Desjardins CA,
    4. Frosch MP,
    5. Schwarzschild MA
    (2013) Postmortem brain levels of urate and precursors in Parkinson's disease and related disorders. Neurodegener Dis 12:189–198, doi:10.1159/000346370, pmid:23467193.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Meissner F,
    2. Molawi K,
    3. Zychlinsky A
    (2010) Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci U S A 107:13046–13050, doi:10.1073/pnas.1002396107, pmid:20616033.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Netea MG,
    2. Nold-Petry CA,
    3. Nold MF,
    4. Joosten LA,
    5. Opitz B,
    6. van der Meer JH,
    7. van de Veerdonk FL,
    8. Ferwerda G,
    9. Heinhuis B,
    10. Devesa I,
    11. Funk CJ,
    12. Mason RJ,
    13. Kullberg BJ,
    14. Rubartelli A,
    15. van der Meer JW,
    16. Dinarello CA
    (2009) Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113:2324–2335, doi:10.1182/blood-2008-03-146720, pmid:19104081.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Olson JK,
    2. Miller SD
    (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916–3924, doi:10.4049/jimmunol.173.6.3916, pmid:15356140.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Pfaffl MW
    (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45, doi:10.1093/nar/29.9.e45, pmid:11328886.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Rabuffetti M,
    2. Sciorati C,
    3. Tarozzo G,
    4. Clementi E,
    5. Manfredi AA,
    6. Beltramo M
    (2000) Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J Neurosci 20:4398–4404, pmid:10844008.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Raivich G,
    2. Banati R
    (2004) Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Brain Res Rev 46:261–281, doi:10.1016/j.brainresrev.2004.06.006, pmid:15571769.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Rock KL,
    2. Kono H
    (2008) The inflammatory response to cell death. Annu Rev Pathol 3:99–126, doi:10.1146/annurev.pathmechdis.3.121806.151456, pmid:18039143.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Salminen A,
    2. Ojala J,
    3. Suuronen T,
    4. Kaarniranta K,
    5. Kauppinen A
    (2008) Amyloid-beta oligomers set fire to inflammasomes and induce Alzheimer's pathology. J Cell Mol Med 12:2255–2262, doi:10.1111/j.1582-4934.2008.00496.x, pmid:18793350.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Schneider M,
    2. Zimmermann AG,
    3. Roberts RA,
    4. Zhang L,
    5. Swanson KV,
    6. Wen H,
    7. Davis BK,
    8. Allen IC,
    9. Holl EK,
    10. Ye Z,
    11. Rahman AH,
    12. Conti BJ,
    13. Eitas TK,
    14. Koller BH,
    15. Ting JP
    (2012) The innate immune sensor NLRC3 attenuates Toll-like receptor signaling via modification of the signaling adaptor TRAF6 and transcription factor NF-kappaB. Nat Immunol 13:823–831, doi:10.1038/ni.2378, pmid:22863753.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Schönbeck U,
    2. Mach F,
    3. Libby P
    (1998) Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 161:3340–3346, pmid:9759850.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Shah VB,
    2. Huang Y,
    3. Keshwara R,
    4. Ozment-Skelton T,
    5. Williams DL,
    6. Keshvara L
    (2008) Beta-glucan activates microglia without inducing cytokine production in Dectin-1-dependent manner. J Immunol 180:2777–2785, doi:10.4049/jimmunol.180.5.2777, pmid:18292498.
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. Shi F,
    2. Yang L,
    3. Kouadir M,
    4. Yang Y,
    5. Wang J,
    6. Zhou X,
    7. Yin X,
    8. Zhao D
    (2012) The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation. J Neuroinflammation 9:73, doi:10.1186/1742-2094-9-73, pmid:22531291.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Shi F,
    2. Yang L,
    3. Kouadir M,
    4. Yang Y,
    5. Ding T,
    6. Wang J,
    7. Zhou X,
    8. Yin X,
    9. Zhao D
    (2013) Prion protein participates in the regulation of classical and alternative activation of BV2 microglia. J Neurochem 124:168–174, doi:10.1111/jnc.12053, pmid:23061439.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Shi Y,
    2. Evans JE,
    3. Rock KL
    (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425:516–521, doi:10.1038/nature01991, pmid:14520412.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Sollberger G,
    2. Strittmatter GE,
    3. Kistowska M,
    4. French LE,
    5. Beer HD
    (2012) Caspase-4 is required for activation of inflammasomes. J Immunol 188:1992–2000, doi:10.4049/jimmunol.1101620, pmid:22246630.
    OpenUrlAbstract/FREE Full Text
  52. ↵
    1. Stehlik C
    (2009) Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis. Arthritis Rheum 60:3524–3530, doi:10.1002/art.24961, pmid:19950297.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Terada K,
    2. Yamada J,
    3. Hayashi Y,
    4. Wu Z,
    5. Uchiyama Y,
    6. Peters C,
    7. Nakanishi H
    (2010) Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia. Glia 58:114–124, doi:10.1002/glia.20906, pmid:19544382.
    OpenUrlCrossRefPubMed
  54. ↵
    1. Ting JP,
    2. Duncan JA,
    3. Lei Y
    (2010) How the noninflammasome NLRs function in the innate immune system. Science 327:286–290, doi:10.1126/science.1184004, pmid:20075243.
    OpenUrlAbstract/FREE Full Text
  55. ↵
    1. van der Putten C,
    2. Zuiderwijk-Sick EA,
    3. van Straalen L,
    4. de Geus ED,
    5. Boven LA,
    6. Kondova I,
    7. Ijzerman AP,
    8. Bajramovic JJ
    (2009) Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia. J Immunol 182:7603–7612, doi:10.4049/jimmunol.0803383, pmid:19494284.
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. Walsh JG,
    2. Reinke SN,
    3. Mamik MK,
    4. McKenzie BA,
    5. Maingat F,
    6. Branton WG,
    7. Broadhurst DI,
    8. Power C
    (2014) Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS. Retrovirology 11:35, doi:10.1186/1742-4690-11-35, pmid:24886384.
    OpenUrlCrossRefPubMed
  57. ↵
    1. Wu Z,
    2. Sun L,
    3. Hashioka S,
    4. Yu S,
    5. Schwab C,
    6. Okada R,
    7. Hayashi Y,
    8. McGeer PL,
    9. Nakanishi H
    (2013) Differential pathways for interleukin-1beta production activated by chromogranin A and amyloid beta in microglia. Neurobiol Aging 34:2715–2725, doi:10.1016/j.neurobiolaging.2013.05.018, pmid:23831373.
    OpenUrlCrossRefPubMed
  58. ↵
    1. Xiao Y,
    2. Jin J,
    3. Chang M,
    4. Chang JH,
    5. Hu H,
    6. Zhou X,
    7. Brittain GC,
    8. Stansberg C,
    9. Torkildsen Ø,
    10. Wang X,
    11. Brink R,
    12. Cheng X,
    13. Sun SC
    (2013) Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation. Nat Med 19:595–602, doi:10.1038/nm.3111, pmid:23603814.
    OpenUrlCrossRefPubMed
  59. ↵
    1. Zhou R,
    2. Yazdi AS,
    3. Menu P,
    4. Tschopp J
    (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469:221–225, doi:10.1038/nature09663, pmid:21124315.
    OpenUrlCrossRefPubMed
  60. ↵
    1. Zuiderwijk-Sick EA,
    2. van der Putten C,
    3. Bsibsi M,
    4. Deuzing IP,
    5. de Boer W,
    6. Persoon-Deen C,
    7. Kondova I,
    8. Boven LA,
    9. van Noort JM,
    10. ‘t Hart BA,
    11. Amor S,
    12. Bajramovic JJ
    (2007) Differentiation of primary adult microglia alters their response to TLR8-mediated activation but not their capacity as APC. Glia 55:1589–1600, doi:10.1002/glia.20572, pmid:17823968.
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 35 (2)
Journal of Neuroscience
Vol. 35, Issue 2
14 Jan 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases
Saskia M. Burm, Ella A. Zuiderwijk-Sick, Anke E.J. ‘t Jong, Céline van der Putten, Jennifer Veth, Ivanela Kondova, Jeffrey J. Bajramovic
Journal of Neuroscience 14 January 2015, 35 (2) 678-687; DOI: 10.1523/JNEUROSCI.2510-14.2015

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Inflammasome-Induced IL-1β Secretion in Microglia Is Characterized by Delayed Kinetics and Is Only Partially Dependent on Inflammatory Caspases
Saskia M. Burm, Ella A. Zuiderwijk-Sick, Anke E.J. ‘t Jong, Céline van der Putten, Jennifer Veth, Ivanela Kondova, Jeffrey J. Bajramovic
Journal of Neuroscience 14 January 2015, 35 (2) 678-687; DOI: 10.1523/JNEUROSCI.2510-14.2015
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • IL-1β
  • inflammasome
  • inflammatory caspases
  • macrophages
  • microglia

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Articles

  • Memory Retrieval Has a Dynamic Influence on the Maintenance Mechanisms That Are Sensitive to ζ-Inhibitory Peptide (ZIP)
  • Neurophysiological Evidence for a Cortical Contribution to the Wakefulness-Related Drive to Breathe Explaining Hypocapnia-Resistant Ventilation in Humans
  • Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase
Show more Articles

Cellular/Molecular

  • Atypical Cadherin FAT2 Is Required for Synaptic Integrity and Motor Behaviors
  • Sex Differences in Histamine Regulation of Striatal Dopamine
  • CXCL12 Engages Cortical Inhibitory Neurons to Enhance Dendritic Spine Plasticity and Structured Network Activity
Show more Cellular/Molecular
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.